Old Web
English
Sign In
Acemap
>
authorDetail
>
J. Sukbuntherng
J. Sukbuntherng
Ibrutinib
Internal medicine
Metabolism
Urine
Excretion
2
Papers
85
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (2)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
RESULTS FROM THE SAFETY RUN-IN PERIOD OF THE SYMPATICO STUDY EVALUATING IBRUTINIB IN COMBINATION WITH VENETOCLAX IN PATIENTS WITH RELAPSED/REFRACTORY MANTLE CELL LYMPHOMA
2019
Hematological Oncology
M. Wang
Radhakrishnan Ramchandren
Robert Chen
L. Karlin
G. Chong
W. Jurczak
K. Wu
Mark J. Bishton
Graham P. Collins
P. Eliadis
F. Peyrade
Kevin J. Freise
J. Sukbuntherng
Y. Lee
E. Dobkowska
V. Fedorov
Jutta K. Neuenburg
Constantine S. Tam
Show All
Source
Cite
Save
Citations (1)
Absorption, Metabolism and Excretion of Oral 14C Radiolabeled Ibrutinib: An Open-label, Phase I, Single-dose Study in Healthy Men
2014
Drug Metabolism and Disposition
Ellen Scheers
Laurent Leclercq
J. de Jong
N. Bode
Marc Bockx
Annouschka Laenen
Filip Cuyckens
Donna Skee
Joseph Murphy
J. Sukbuntherng
Geert Mannens
Show All
Source
Cite
Save
Citations (84)
1